Digital strategies and standardized data models cut manual work, boost accuracy and speed of information sharing, and build trust between sponsors and CMOs.
- Exploring The Benefits Of Electroporation In NK Cell Transfection
- On The Potency Assurance Journey, Travelers Need A Road Map
- It's Not Just You, Everyone's Talking About OPV
- Guidelines For Defining A Control Strategy Framework For Accelerated mAb Programs
- A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
EDITOR'S DESK
-
On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
AI consultant Kat Kozyrytska advocates for ethical AI adoption and explains its potential to foster collaboration across the industry.
Takeda head of process development, Amy Shaw, explains what factors to consider when scaling up or scaling out cell therapy manufacturing.
DeciBio partner Carl Schoellhammer, Ph.D., speaks on the record with Bioprocess Online's chief editor Tyler Menichiello at the 2025 BioProcess International conference in Boston.
Nobel laureate, David Baltimore passed away at 87 years old, on September 6, 2025. He was widely regarded as a scientific visionary who at just 37, co-discovered reverse transcriptase, an enzyme that flipped molecular biology on its head by showing that genetic information could flow from RNA back to DNA, not just the other way around.
During a Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up," panelists discuss a way forward for the industry to unlock the true flexibility and promise of single-use technology.
GUEST COLUMNISTS
-
Sensitive Critical Starting Materials Need A 'Just-In-Data' Approach
Here's a blueprint for transforming the fragmented, high-risk interface between vector and cell therapy platforms into a unified, predictable, and compliant system.
-
Exploring The Benefits Of Electroporation In NK Cell Transfection
Electroporation creates temporary holes in cell membranes for genetic material to slip through. The technique offers some key advantages to viral transduction.
-
On The Potency Assurance Journey, Travelers Need A Road Map
When regulatory expectations change by the phase, the route can be difficult and confusing to navigate for both new and experienced potency investigators.
-
It's Not Just You, Everyone's Talking About OPV
Ongoing process verification has evolved beyond a compliance exercise to a strategic priority thanks, in part, to technology advancements.
-
Guidelines For Defining A Control Strategy Framework For Accelerated mAb Programs
This article assembles an industrywide “platform” knowledge base on the impact of parameters across unit operations in a standard mAb process.
-
A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
The transition from 2D to 3D cell culture requires a combination of advanced analytical techniques, but aligning new methods with established principles can be challenging.
-
Global Implications Of Zero Tariffs On Indian Pharma Exports To China
Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
Among other reasons, academic centers have access to sophisticated technology. In contrast, manufacturing suites must use established, validated methods.
BIOPROCESSING WHITE PAPERS
-
Liposomal And Nanoparticle Technology
Specializing in oncology, anti-infective, and complex formulations, Pfizer Melbourne provides manufacturing services for sterile dosage forms.
-
Leveraging The Immunological Diversity Of The Pentamice® Platform For Covid-19 Antibody Discovery5/16/2024
Consider this alternative immunization approach — the PentaMice platform, a collection of five wildtype mouse strains bred in-house for increased MHC class II diversity — and how we're leveraging it for COVID-19 antibody discovery.
-
Maximize Your Laboratory Efficiency10/20/2025
Gain insight into how labs can boost productivity by reducing downtime, minimizing errors, and increasing walk-away time through real-time insights and analytics.
-
Achieving Rapid, High-Titer Expression For Next-Generation Biologics3/5/2025
This advanced cell line development technology overcomes production challenges related to the expression and scalability of complex biologics.
-
Exploring The Future Of Viral Vector Development And Production1/17/2024
The demand for viral vectors continues to grow, making addressing the challenges related to their manufacturing and scale-up increasingly critical.
-
Quality By Design: The Importance Of Reference Standards In Drug Development8/1/2024
Learn more about the comprehensive lifecycle management of reference standards, encompassing qualification, characterization, and storage procedures.
BIOPROCESSING APP NOTES & CASE STUDIES
- FDA Releases Draft Guidance To Accelerate Biosimilar Development
- Supporting The Next Generation Of ADCs
- AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing
- On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
- On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing
- On The Ground At BPI: Industry Reflections With Carl Schoellhammer, Ph.D.
- Single-Use Standardization Starts At Home
BIOPROCESS ONLINE CONTENT COLLECTIONS
This collection of articles digs into the industry’s growing focus on knowledge management as an indispensable facet of biomanufacturing and pharmaceutical development, exploring how it plays into risk management, quality, vendor relationships, and supply chain resilience.
More Content CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- Accelerating Early Phase Biologics From The Clinic To Commercialization
- Accelerate Your pDNA And mRNA Process Development
- GMP Twins: Making Digital Twins Real In GxP Manufacturing
- Driving Robust Tech Transfer In Biologics: CFD Simulation
- Practical Solutions For Protein Analytics And Residual DNA Testing
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 11.17.25 -- From Breakdown To Breakthrough: Asset Performance Management
- 11.17.25 -- Streamline Your Workflow With Single-Use 2L Bioprocess Bags
- 11.17.25 -- How Sethera Harnesses A Promiscuous Enzyme To Make Recombinant Peptides
- 11.14.25 -- Overcoming Roadblocks To Advanced Therapy Manufacture
- 11.14.25 -- STREAM Edition: Navigating The Complexity Of Conditionally Active Biologics